Literature DB >> 21599602

Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current uses.

Thomas M Habermann1, Kanti Rai.   

Abstract

The management of hairy cell leukemia has undergone historic unprecedented changes since three decades ago. This review summarizes treatment approaches utilized before the adenosine deaminase inhibitors. These historic approaches may still be utilized in patients with relapsed or refractory disease.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21599602     DOI： 10.3109/10428194.2011.573033

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


  8 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

Review 2.  Hairy cell leukemia: present and future directions.

Authors:  Robert J Kreitman
Journal:  Leuk Lymphoma       Date:  2019-05-09

Review 3.  Immunoconjugates and new molecular targets in hairy cell leukemia.

Authors:  Robert J Kreitman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 4.  [Hairy cell leukemia].

Authors:  S Dietrich; M Andrulis; T Zenz
Journal:  Internist (Berl)       Date:  2015-04       Impact factor: 0.743

Review 5.  Update on hairy cell leukemia.

Authors:  Robert J Kreitman; Evgeny Arons
Journal:  Clin Adv Hematol Oncol       Date:  2018-03

6.  An Unusual Giant Leg Ulcer as a Rare Presentation of Sweet's Syndrome in a Patient with Hairy Cell Leukemia Successfully Managed by Splenectomy.

Authors:  Hakan Özdoğu; Mahmut Yeral; Can Boğa
Journal:  Turk J Haematol       Date:  2017-03-08       Impact factor: 1.831

7.  Hairy cell leukemia: short review, today's recommendations and outlook.

Authors:  V Maevis; U Mey; G Schmidt-Wolf; I G H Schmidt-Wolf
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037

Review 8.  Skin changes in hairy cell leukemia.

Authors:  Ewa Robak; Dorota Jesionek-Kupnicka; Tadeusz Robak
Journal:  Ann Hematol       Date:  2020-11-20       Impact factor: 3.673
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.